Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Oman

Oman

The projected revenue for the Other Vaccines market in Oman is expected to reach US$17.87m in 2024.
It is estimated that the revenue will show an annual growth rate (CAGR 2024-2029) of 10.78%, leading to a market volume of US$29.81m by 2029.
When compared globally, United States is anticipated to generate the highest revenue, amounting to US$24,730.00m in 2024.
Oman's increasing focus on public health has led to a growing demand for other vaccines, creating opportunities for pharmaceutical companies in the country.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for Other Vaccines in Oman has been steadily increasing in recent years.

Customer preferences: Customers in Oman are becoming increasingly aware of the importance of vaccination. This is partly due to the government's efforts to educate the public on the benefits of vaccination. As a result, there has been a growing demand for Other Vaccines in the country.

Trends in the market: One of the key trends in the Other Vaccines market in Oman is the increasing popularity of travel vaccines. With more Omanis traveling abroad for work or leisure, there has been a growing demand for vaccines that protect against diseases such as yellow fever, typhoid, and hepatitis A. Another trend in the market is the growing demand for vaccines that protect against diseases such as HPV and meningitis. This is partly due to the increasing awareness of these diseases among the general public.

Local special circumstances: One of the key factors driving the demand for Other Vaccines in Oman is the country's large expatriate population. Many expatriates come from countries where certain diseases are more prevalent, and they require vaccination before entering Oman. Additionally, Oman has a large number of migrant workers who also require vaccination before entering the country.

Underlying macroeconomic factors: Oman's economy has been growing steadily in recent years, which has led to an increase in disposable income among the population. This has made it easier for people to afford vaccination, which has contributed to the growing demand for Other Vaccines in the country. Additionally, Oman's healthcare sector has been expanding rapidly, with the government investing heavily in healthcare infrastructure and services. This has made it easier for people to access vaccination, which has also contributed to the growing demand for Other Vaccines.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.